Pascal and Francis Bibliographic Databases



Selection :

Permanent link

The long-term effect of specific type II 5α-reductase inhibition with finasteride on bone mineral density in men: Results of a 4-year placebo controlled trial

MATSUMOTO, Alvin M; TENOVER, Lisa; ZHANG, Gang K; SCHMIDT, Joseph; TAYLOR, Alice M; LEE, Michael; WALDSTREICHER, Joanne; MCCLUNG, Michael; MOBLEY, David; GELLER, Jack; SULLIVAN, Michael; GRAYHACK, John; WESSELLS, Hunter; KADMON, Dov; FLANAGAN, Malachi
Baylor College of Medicine, Houston, Texas, United States
Emory University, Atlanta, Georgia, United States
Merck & Co., Inc., Rahway, New Jersey, United States
Mercy Research Clinic, San Diego, California, United States
Northwestern University, Chicago, Illinois, United States
Oregon Osteoporosis Center, Portland, Oregon, United States
Park Nicollet Clinic, Minneapolis, Minnesota, United States
Research for Health, Inc, Houston, Texas, United States
Rush Presbyterian Medical Center, Chicago, Illinois, United States
University of Arizona, Tucson, Arizona, United States
University of California, San Diego, California, United States
VA Puget Sound Health Care System and University of Washington, Seattle, Washington, United States
PLESS Study Group

The Journal of urology. 2002, Vol 167, Num 5, pp 2105-2108 ; ref : 20 ref

Scientific domain
Urology, nephrology
Lippincott Williams & Wilkins, Hagerstown, MD
Publication country
United States
Document type
Keyword (fr)
Absorptiométrie biphotonique Adénome Antiandrogène Anticancéreux Antihormone Azastéroïde Chimiothérapie Densité minérale osseuse Etude double insu Etude en condition contrôlée Finastéride Homme Long terme Placebo Prostate Résultat Traitement Appareil génital mâle pathologie Appareil urinaire pathologie Prostate pathologie Tumeur bénigne
Keyword (en)
Dual energy absorptiometry Adenoma Antiandrogen Antineoplastic agent Antihormone Azasteroid Chemotherapy Bone mineral density Double blind study Controlled environment study Finasteride Human Long term Placebo Prostate Result Treatment Male genital diseases Urinary system disease Prostate disease Benign neoplasm
Keyword (es)
Espectrometría absorción bifotónica Adenoma Antiandrógeno Anticanceroso Antihormona Azasteroide Quimioterapia Masa mineral ósea Estudio doble ciego Estudio en condición controlada Finasterida Hombre Largo plazo Placebo Prostata Resultado Tratamiento Aparato genital macho patología Aparato urinario patología Prostata patología Tumor benigno
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R02 Chemotherapy

Pharmacological treatments
INIST identifier

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web